Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115572317B reveals optimized esterification. Delivers high-purity pharmaceutical intermediates with reduced purification burden for supply chain stability.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.
Patent CN101391997B details a safer emtricitabine intermediate synthesis using triphosgene. Discover cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN109020872B details a novel method converting unwanted paroxetine isomers into valuable racemic intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.
Novel manganese-catalyzed process for carfilzomib intermediates significantly reduces cost and waste. Reliable pharmaceutical intermediate supplier for global scale manufacturing.
Patent CN102070611A reveals a high-yield, two-step Hantzsch route for amlodipine intermediates, offering significant cost reduction and scalable manufacturing for global API producers.
Patent CN113512569B details a green enzymatic route for Lopinavir intermediates. Achieve high purity and cost reduction in API manufacturing with our advanced biocatalytic solutions.
Advanced patent CN104016954A method for nebivolol intermediate. High yield, >99% purity, scalable process for reliable pharmaceutical intermediate supplier.
Patent CN105949217A reveals TEMPO oxidation for milbemycin oxime intermediate. Offers high purity, cost reduction in pharmaceutical intermediates manufacturing, and scalable supply.
Novel patent CN109678855A offers high-yield Avibactam intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers.
Novel patent CN112939900B offers high-yield brivaracetam intermediate synthesis with simplified chiral resolution for reliable pharmaceutical intermediate supply chains.
Patent CN101935302A details a novel organocatalytic route for Huperzine A intermediates, offering high optical purity and eliminating precious metal dependency for reliable pharmaceutical intermediate supply.
Patent CN107935912A details safe efficient amlodipine intermediate preparation reducing hazards and costs for pharmaceutical supply chains globally ensuring high purity standards.
Patent CN107001250A reveals a novel reduction method for Odanacatib intermediates, offering enhanced purity and scalable manufacturing for global supply chains.
Advanced patent CN104860975B enables cost-effective bortezomib intermediate production. Enhanced yield and purity for reliable pharmaceutical supply chains.
Advanced patent CN106478437A enables efficient Sacubitril intermediate production. Reduced impurities and scalable routes ensure reliable supply chain solutions for global pharmaceutical partners.
Patent CN111533662B details a cost-effective synthesis of citalopram intermediates using accessible halogenated benzoic acids, offering significant supply chain advantages.
Patent CN114907300B details a cost-effective route for Tazemetostat intermediates, offering enhanced purity and scalable manufacturing for global supply chains.
Patent CN106478484A reveals advanced purification for Almogran intermediate. Achieve higher yield and purity for reliable pharmaceutical intermediates supply chain.
Novel Ru-catalyzed asymmetric hydrogenation route for Niraparib intermediate. High yield, scalable process for pharmaceutical supply chains.